Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Kadimastem to Collaborate with Merck Serono

Published: Tuesday, August 12, 2014
Last Updated: Tuesday, August 12, 2014
Bookmark and Share
Collaboration agreement to advance combined efforts in neurodegenerative disease area.

Kadimastem reports that it has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis (MS), and potential other neurodegenerative diseases. Kadimastem will utilize its unique platform for Merck Serono, the biopharmaceutical division of Merck, for the screening of new compounds as potential new therapeutics.

Kadimastem has developed a technology to differentiate stem cells into oligodendrocytes, cells required in the brain to produce myelin, the insulation for the neural wiring. In MS, oligodendrocytes are destroyed by the immune system. Kadimastem is also equipped to generate stem cell-derived astrocytes. Astrocytes are neural supporting cells shown to be involved in neurodegenerative diseases.

Within the collaboration, Kadimastem will screen compounds in proprietary assays based on these myelin-producing cells and differentiated nerve supporting cells, with the aim of identifying compounds with potential efficacy in MS, and potential effect in other neurodegenerative diseases.

The transaction is consistent with Kadimastem's strategy to produce short term revenues and to develop closer ties with large international pharmaceutical companies for drug screening projects. Drug-screening will be performed with cells that Kadimastem produces routinely for its own cell-therapy products. Kadimastem’s drug-screening platforms comprising human cells can help to predict the potential a drug will eventually have to impact different cell types including oligodendrocytes.

Yossi Ben-Yossef, Kadimastem's CEO, noted that “the collaboration with Merck strengthens the already fruitful relationship between the two companies and is a vote of confidence by Merck Serono in Kadimastem and its innovative technology. The fact that we recently signed a drug screening contract with another pharmaceutical giant is an indication of the scientific merit and maturity of our technology. This reflects an increased understanding that we have the ability to significantly contribute to the drug development process and to shorten timelines.”

Prof. Michel Revel, Kadimastem’s Chief Scientist, added that “the decision by Merck to sign an agreement with us for drug screening shows the excellence of the technology we have developed for creating myelin-producing cells and nerve-supporting cells. We are convinced that the screening assays we are conducting using these cells are accurate, sensitive, and reproducible. Our technology enables discovery of chemical agents that could lead to a new generation of drugs for treating diseases that seriously damage the central nervous system, such as MS and ALS, amyotrophic lateral sclerosis.”

Upon signing of the agreement, Merck will pay Kadimastem an initial fee, and additional payments which are contingent on the achievement of certain milestones. Further financial details are not disclosed.

The collaboration agreement follows a previous agreement between both companies from 2012, and the signature of a memorandum of understanding in 2013 aimed at utilizing Kadimastem’s screening platform to characterize new compounds that may lead to next generation neurodegenerative disease therapeutics.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Fat Cells Originating from Bone Marrow Found in Humans
Cells could contribute to diabetes, heart disease.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
CRI Identifies Emergency Blood-formation Response
Researchers report that when tissue damage occurs, an emergency blood-formation system activates.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Advancing Genome Editing of Blood Stem Cells
Genome editing techniques for blood stem cells just got better, thanks to a team of researchers at USC and Sangamo BioSciences.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos